Tristel Regulatory News (TSTL)

7 September 2011

TRISTEL plc

Full regulatory approval for Fuse and Jet in China

Tristel plc (AIM: TSTL), the manufacturer of infection control, contamination control and hygiene products, announces that it has received the administrative licences to sell its medical instrument disinfectant "Fuse" and surface disinfectant "Jet" from the Chinese Health authorities.

Tristel Fuse is a mixable sachet which contains a single, easy to use dose of Tristel's proprietary chlorine dioxide chemistry. Fuse is first activated within the sachet and then simply added to five litres of water to create the correct concentration for cleaning and disinfection of medical instruments. Immediately ready for use, Fuse delivers a safe and highly effective consumable to work within its sophisticated micro-processor controlled tray band named "Stella", into which medical instruments are immersed. Tristel received full approval to sell their Stella product in China earlier this year, as announced on 12 May 2011.

Tristel Jet is a non-aerosol gel-based trigger spray which permits accurate directional application of Tristel's chlorine dioxide chemistry to hard surfaces. Its thickened formulation eliminates any health and safety concerns associated with aerosols.

Paul Swinney, Chief Executive of Tristel, said: "Our product approval programme in China is progressing well. With the inclusion of Tristel Jet within our offering we now address two important areas of infection control in China: medical instrumentation and hospital surfaces. Worldwide export sales are forecast to be a major contributor to our top-line growth this year."

For further information, please contact: